BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2012
View Archived Issues
New vaccine shows promise to treat drug addiction
Read More
Santaris Pharma identifies new candidate gene therapies for cancer
Read More
Novel antibacterials presented by MicuRx Pharmaceuticals
Read More
U.S. university patents new histone demethylase inhibitors
Read More
Anacor develops novel antibacterial and antimycobacterial agents
Read More
New potential therapies for HIV infection reported by Roche
Read More
Investigation at Novartis yields novel ENaC antagonists
Read More
Novel PFK/FBPase inhibitors divulged by Kancera
Read More
Zannan and AB Pharma develop novel highly potent HCV NS3/NS4A inhibitor
Read More
Small ApoA-I mimetic is atheroprotective and can be used to image atherosclerotic plaques
Read More
New potential oral cancer therapy developed in Korea
Read More
Novel thiazolidinediones created in Brazil
Read More
Promising first clinical results reported on Affimed TandAb
Read More
Veles Pharma prepares innovative drugs for launch
Read More
Effective antiviral biosimilar immunotherapy produced by iBioLaunch technology
Read More
Arteriocyte obtains FDA clearance for compartment syndrome trial
Read More
Joint research for metabolic disease therapies advances
Read More
Bayer HealthCare submits new MAA for Xarelto
Read More
Agreement seeks to develop companion diagnostic for Adcetris
Read More
Novel anti-infectives disclosed by State University of New Jersey
Read More
AnGes and BioLeaders enter agreement on oral vaccine for hypertension
Read More
Alchemia provides update on pivotal HA-irinotecan trial
Read More
AstraZeneca and DNDi enter drug screening collaboration
Read More
Shire signs new acquisition agreement
Read More
OPKO Health kicks off phase III program for rolapitant
Read More